Physician profile
Jake Michael Smith
NPI 1528528551
$962.08
in general payments reported to CMS, 2019-2025
15 companies · $120 in 2025
The $120 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.36 · 2023: $277 · 2024: $473 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $331.37 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.65 | 2023-2025 | Lifevest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.51 | 2022-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $49.99 | 2022-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $45.37 | 2023-2024 | Farxiga |
| Pfizer INC. | $45.22 | 2022-2024 | |
| Inari Medical, INC. | $41.69 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $41.63 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $34.94 | 2023-2024 | |
| Ucb, INC. | $26.79 | 2022 | |
| Asahi Intecc USA, INC. | $20.99 | 2024 | Peripheral Vascular |
| Janssen Pharmaceuticals, INC | $19.87 | 2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $18.33 | 2025 | Amvuttra |
| Boston Scientific Corporation | $16.57 | 2025 | General - Ep |
| Abbvie INC. | $15.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.